Clearance Summary
Spaulding Electrocardiograph 2100iQ received FDA 510(k) clearance under submission number K150564, sponsored by Spaulding Clinical Research, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2015-08-12.
- Submission: K150564
- Applicant / Sponsor: Spaulding Clinical Research, LLC
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2340
- Decision date: 2015-08-12
Classification & Regulation
This clearance is catalogued under FDA product code DPS and 21 CFR 870.2340, within the Cardiovascular review panel as a Class II device.